- $221.21m
- $154.31m
- $408.52m
Brief: Nevro Names New Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
Brief: Nevro Q1 revenue USD 96.327 million
Nevro Corp reports results for the quarter ended in March - Earnings Summary
Brief: Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance And Reiterates Full-Year 2023 Guidance
Nevro Corp expected to post a loss of $1.04 a share - Earnings Preview
Brief: Nevro Corp Enrolls First Patient In PDN Sensory Study
Brief: Nevro sees FY revenue of USD 445-455 million
U.S. RESEARCH ROUNDUP- Axonics, Chipotle Mexican Grill, ResMed
Brief: Nevro Announces U.S. Market Launch Of Spinal Cord Stimulation System
Brief: Nevro Announces Fourth Quarter And Full-Year 2022 Financial Results
Nevro Corp reports results for the quarter ended in December - Earnings Summary
Nevro Corp expected to post a loss of 49 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Abbott Laboratories, Navient Corp, Tesla
MedTech's macro struggles may ease by H2 2023 - Citi
Brief: Nevro Sees FY23 Revenue In Range Of $445 Mln-$455 Mln
Brief: Nevro Announces Two Presentations From Clinical Trials Have Been Accepted For Late-Breaking Abstract Sessions At Nans 2023 Annual Meeting
NYSE ORDER IMBALANCE 59841.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP- Boeing, Intel, Silvergate Capital